FEATURED

Quantum’s New Reality Check

Something happened in early June that most people in this sector glossed over. Not because it was subtle. Because it was inconvenient.

Quantinuum went public.

On June 3, QNT priced at $60 a share, raised $1.68 billion in an upsized offering of 28 million shares, and opened its first day of trading at $68 — above the already-raised range. Market cap at close: roughly $15.7 billion. The company was assembled from the 2021 merger of Honeywell Quantum Solutions and Cambridge Quantum, and Honeywell still controls approximately 48.1% of combined voting power. This was not a SPAC with a PowerPoint. It came with a full prospectus, a real anchor shareholder, and named enterprise relationships including JPMorgan Chase and Amgen.

That matters more than most people are giving it credit for.

Here is the thing about the quantum sector before QNT arrived: it was built almost entirely on SPAC-era credibility. IonQ, Rigetti, D-Wave — all came to market through blank-check vehicles with thinner institutional scrutiny and more promotional roadmaps than a traditional IPO process allows. That is not a knock. It is just the context. Now there is a traditionally IPO’d peer sitting in the same space, and every comparison that investors used to make in a vacuum suddenly has a new data point on the right side of the ledger.

Slight tangent, but it matters: the quantum sector has been one of the most punishing places to own stocks over the past two years in terms of insider behavior. IonQ, Rigetti, and D-Wave insiders have collectively been net sellers of approximately $857 million more stock than they purchased since mid-2021. IonQ insiders put in roughly $2.25 million in cumulative purchases over that stretch. D-Wave insiders bought a total of $1,795. Rigetti insiders have not made a single open-market purchase. Not one. The people running these companies, who know the technology and the timelines better than anyone, have not been buyers. That does not automatically kill the investment case. Insiders at early-stage tech companies face trading restrictions and often hold illiquid concentrated positions. But it belongs in the honest version of this conversation.

Back to the numbers.

All four names are pre-profit. No exceptions. The entire investment case in quantum right now is a bet on commercialization timelines that are still measured in years. That is the baseline every investor in this space is operating from, whether they say it out loud or not.

What is interesting is how differently each company looks once you actually sit with the Q1 2026 results. IonQ reported $64.7 million in revenue — up 755% year over year — and beat Wall Street consensus by roughly 30%. After the quarter, management raised full-year 2026 guidance to $260-$270 million, implying close to 100% organic growth. Cash, equivalents, and investments came in at $3.1 billion as of March 31. For a sector full of companies burning money with minimal commercial traction, that balance sheet is a different animal entirely. Q2 guidance was set at $65-$68 million at the midpoint, so the first real test of whether the full-year number is tracking comes soon.

Rigetti posted $4.4 million in Q1 revenue, up 193% year over year. That is real growth off a small base — the company was doing about $1.5 million a year ago. Hardware is advancing: Rigetti launched its 108-qubit Cepheus-1-108Q system into general availability and holds an $8.4 million purchase order to deliver a system to India’s Centre for Development of Advanced Computing (C-DAC) in the second half of 2026. But $4.4 million in quarterly revenue against a stock that was trading at a price-to-sales ratio of 836 as of late May is a hard conversation. The commercialization gap between the hardware progress and the revenue line is still wide.

D-Wave is the one that requires the most patience to read correctly. Q1 revenue came in at $2.9 million, down 81% year over year — and yes, the stock got hit for it. But the prior-year quarter included a one-time $12.6 million system sale that did not repeat. Strip that out and the picture changes. Bookings for Q1 2026 rose 1,994% year over year to $33.4 million. Remaining performance obligations reached $42.4 million, up 563%. That is contracted future revenue already sitting on the books. D-Wave also holds a structural position nobody else in the sector occupies: it is the only dual-platform company spanning both quantum annealing and gate-model systems, following its acquisition of Quantum Circuits. Its annealing hardware is already in commercial use for enterprise optimization — real customers, real contracts — while everyone else is still on the path toward fault-tolerant systems that do not exist yet at commercial scale. The late-May price-to-sales ratio of 791 is hard to defend on current revenue. The bookings trajectory is harder to ignore.

Quantinuum reported $30.9 million in full-year 2025 revenue, up about 35%, with a net loss of $192.6 million. Q1 2026 revenue was $5.2 million, down about 73% year over year — but the comparison is distorted by a large sales-type lease in the prior year that did not recur. Still, the Q1 drop was steep, and investors in QNT are being asked to underwrite a patient, years-long commercialization story at a $15+ billion valuation. The full-stack approach, Honeywell backing, and traditional IPO pedigree are genuine differentiators. The revenue, at this stage, is not.

On the policy side, there is real movement. In May 2026, the Department of Commerce announced $2.013 billion in planned CHIPS Act letters of intent across nine quantum companies. IBM anchored the program at $1 billion for a new quantum foundry subsidiary. GlobalFoundries received a $375 million allocation. And Quantinuum, D-Wave, and Rigetti each received separate $100 million LOIs. The government takes a minority, non-controlling equity stake in each recipient as part of the structure. Then on June 22, President Trump signed two executive orders targeting national quantum capabilities — one directing delivery of a science-enabling quantum computer to a Department of Energy facility by 2028, the other requiring federal agencies to migrate high-value systems to post-quantum cryptography by 2030 and 2031. That is not a vague funding story anymore. That is a federal timeline with hard targets.

Here is where I am at on this. The QNT IPO did something useful: it forced a valuation conversation that was getting too comfortable. IonQ at a 109 price-to-sales ratio is expensive by any normal standard — but inside this sector, next to names trading at 791 and 836, with a $3.1 billion balance sheet and $260-$270 million in 2026 guidance, it reads differently. That is not an endorsement. It is a relative observation about a sector that does not offer cheap options.

What I keep coming back to is D-Wave’s bookings number. A 1,994% year-over-year increase is not a rounding error. Whether that converts to revenue on a timeline that justifies the current valuation is the actual question — and nobody has a clean answer to it yet.

The next read on all of this is IonQ’s Q2 2026 earnings. That is the first real checkpoint on whether the $260-$270 million full-year guide is tracking or starting to slip. If it slips, this whole sector feels it.

This is not investment advice. All data sourced from SEC filings, company prospectuses, and publicly available analyst coverage as of June 26, 2026. Quantum computing stocks are highly speculative and involve significant risk of loss.